Combined oral contraceptive use and venous thrornboernbolism

Gynecological Endocrinology

Volumn 10, Issue sup2, 1996, Pages 13-18

  Hannaford, P C ^a  

^a ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

ORAL CONTRACEPTIVES; VENOUS THROMEIOEMBOLIC DISEASE

Indexed keywords

EID: 0346159217     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513599609045620     Document Type: Article

References (35)

1. Jordan W. M. Pulmonary embolism. Lancet 1961; 2: 1146 – 7
2. Tyler E. T. Oral contraception and venous thrombosis. J. Am. Med. Assoc. 1963; 185: 131 – 2
3. Ad Hoc Advisory Committee for the Evaluation of a Possible Etiologic Relation with Thromboembolic Conditions. FDA Report on Enovid. J. Am. Med. Assoc. Sept. 7, 1963; 185: 776
4. Cahal D. A. Safety of oral contraceptives. Br. Med. J. 1965; 4: 1180
5. WHO Scientific Group. Clinical aspects of oral gestogens. Report of a WHO Scientific Group. World Health Organization Technical Report Series 1966, WHO, Geneva 1966, No. 326
6. Records Unit and Research Advisory Service of the Royal College of General Practitioners. Oral contraception and thromboembolic disease. J. Coll. Gen. Practit. 1967; 13: 267 – 79
7. Innian W. H.W., Vessey M. P. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br. Men. J. 1968; 2: 193 – 9
8. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br. Med, J. 1968; 2: 199 – 205
9. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br. Med. J. 1969; 2: 651 – 7
10. Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am. J. Epidemiol. 1969; 90: 365 – 80
11. Boston Collaborative Drug Surveillance Programme. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall-bladder disease, and breast tumours. Lancet 1973; 1: 1399 – 404
12. Stolley P. D., Tonascia J. A., Tockman M. S., Sartwell P. E., Rutledge A. H., Jacobs M. P. Thrombosis with low-estrogen oral contraceptives. Am. J. Epidemiol. 1975; 102: 197 – 208
13. Maguire M. G., Tonascia J., Sartwell P. E., Stolley P. D., Tockman D. S. Increased risk of thrombosis due to oral contraceptives: a further report. Am. J. Epidemiol. 1979; 110: 188 – 95
14. Helmrich S. P., Rosenberg L., Kaufman D. W., Strom B., Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet. Cynecol. 1987; 69: 91 – 5
15. Vandenbroucke J. P., Koster T., Briët E., Reitsma P. H., Bertina R. M., Rosendaal F. R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453 – 7
16. Thorogood M., Mann J., Murphy M., Vessey M. Risk factors for fatal venous thromboembolism in young women: a case-control study. Int. J. Epidemiol. 1992; 21: 48 – 52
17. Royal College of General Practitioners' Oral Contraception Study. Oral contraceptives, venous thrombosis, and varicose veins. J. R. Coll. Gen. Practit. 1978; 28: 393 – 9
18. Petitti D. B., Winegerd J., Pellegrin F., Ramcharan S. Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. Am. J. Epidemiol. 1978; 108: 480 – 5
19. Vessey M., Mant D., Smith A., Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br. Med. J. 1986; 292: 526
20. Porter J. B., Hunter J. R., Danielson D. A., Jick H., Stergachis A. Oral contraceptives and nonfatal vascular disease — recent experience. Obstet. Gynecol. 1982; 59: 299 – 302
21. Porter J. B., Hunter J. R., Jick H., Stergachis A. Oral contraceptives and nonfatal vascular disease. Obstet. Gynecol. 1985; 66: 1 – 4
22. Farmer R. T., Preston T. D. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J. Obstet. Gynaecol. 1995; 15: 195 – 200
23. Gerstman B. B., Piper J. M., Tomita D. K., Ferguson W. J., Stadel B. V., Lundin F. E. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am. J. Epidemiol. 1991; 133: 32 – 7
24. Glass R., Johnson B., Vessey M. Accuracy of recall of histories of oral contraceptive use. Br. J. Prev. Soc. Med. 1974; 28: 273 – 5
25. Stolley P. D., Tonascia J. A., Sartwell P. E., Tockman M. S., Tonascia S., Rutledge A., Schinner R. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am. J. Epidemiol. 1978; 107: 226 – 35
26. Sartwell P. E. Oral contraceptives and thromboembolism: a further report. Am. J. Epidemiol. 1971; 94: 192 – 201
27. Lawson D. H., Davidson J. F., Jick H. Oral contraceptive use and venous thromboembolism: absence of an effect of smoking. Br. Med. J. 1977; 2: 729 – 30
28. Jick H., Slone D., Westerholm B., Inman W. H. W., Vessey M. P., Shapiro S., Lewis G. P., Worcester J. Venous thromboembolic disease and ABO blood type. Lancet 1969; 1: 539 – 42
29. Böttiger L. E., Wersterholm B. Oral contraceptives and thromboembolic disease. Acta Med. Scand. 1971; 190: 455 – 63
30. Thorogood M., Vessey M. P. Trends in use of oral contraceptives in Britain. Br. J. Fam. Plann. 1990; 16: 41 – 53
31. Inman W. H. W., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br. Med. J. 1970; 2: 203 – 9
32. Böttiger L. E., Boman G., Eklund G., Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1: 1097 – 101
33. Meade T. W., Greenberg G., Thompson S. G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br. Med. J. 1980; 2: 1157 – 61
34. Royal College of General Practitioners' Oral Contraception Study. Further analyses of mortality in oral contraceptive users. Lancet 1981; 1: 541 – 6
35. Vessey M. P., Villiard-Mackintosh L., McPherson K., Yeates D. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. Br. Med. J. 1989; 299: 1487 – 91